| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.35▼ | 1.37▼ | 1.37▼ | 1.40▼ | 1.58▼ |
| MA10 | 1.36▼ | 1.36▼ | 1.36▼ | 1.48▼ | 1.64▼ |
| MA20 | 1.41▼ | 1.45▼ | 1.45▼ | 1.59▼ | 3.35▼ |
| MA50 | 1.50▼ | 1.55▼ | 1.56▼ | 1.67▼ | 6.12▼ |
| MA100 | 1.60▼ | 1.65▼ | 1.65▼ | 3.44▼ | 25.23▼ |
| MA200 | 1.66▼ | 1.74▼ | 1.90▼ | 5.72▼ | 1,126.07▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.003▼ | -0.003▼ | -0.016▼ | 0.106▲ |
| RSI | 28.888▼ | 31.484▼ | 31.660▼ | 31.915▼ | 30.541▼ |
| STOCH | 34.957 | 50.241 | 39.760 | 11.226▼ | 9.787▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -96.721▼ | -99.324▼ |
| CCI | -114.163▼ | -104.654▼ | -95.099 | -122.715▼ | -91.537 |
|
Sunday, October 18, 2026 07:08 PM
(MENAFN- Investor Brand Network) TransCode Therapeutics (NASDAQ: RNAZ), a clinical-stage company developing immuno-oncology and RNA-based therapeutics for high-risk and advanced cancers, announced ...
|
|
Saturday, July 18, 2026 02:39 PM
TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. RANK tracks the performance of the ...
|
|
Thursday, May 01, 2025 01:33 AM
TransCode Therapeutics, Inc. (NASDAQ:RNAZ) announced further progress on Thursday in its Phase 1a clinical trial of TTX-MC138 in patients with metastatic cancer. To date, 13 patients have received at ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/26 | 1.43 | 1.45 | 1.30 | 1.32 | 20,877 |
| 12/11/26 | 1.36 | 1.47 | 1.35 | 1.3904 | 13,940 |
| 11/11/26 | 1.33 | 1.44 | 1.33 | 1.40 | 11,993 |
| 10/11/26 | 1.51 | 1.55 | 1.33 | 1.35 | 24,040 |
| 09/11/26 | 1.57 | 1.59 | 1.50 | 1.54 | 16,177 |
| 06/11/26 | 1.53 | 1.56 | 1.45 | 1.49 | 12,793 |
| 05/11/26 | 1.63 | 1.67 | 1.475 | 1.51 | 20,450 |
| 04/11/26 | 1.61 | 1.7198 | 1.57 | 1.60 | 7,099 |
| 03/11/26 | 1.60 | 1.65 | 1.50 | 1.57 | 29,550 |
| 02/11/26 | 1.69 | 1.69 | 1.61 | 1.63 | 16,520 |
|
|
||||
|
|
||||
|
|